MBE Wealth Management’s Gilead Sciences GILD Stock Holding History

MBE Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-59	Closed	-$4K	–	227
2020 Q1	$4K	Buy	+59	New	+$4.08K	﹤0.01%	394

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MBE Wealth Management's GILD Position: Q2 2020 in Review

MBE Wealth Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 59 shares — an estimated $4K sold.

MBE Wealth Management first reported a position in GILD in Q1 2020 and held it in 1 quarter. The position peaked at $4K in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

MBE Wealth Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
MBE Wealth Management sold 59 Gilead Sciences shares in Q2 2020, an estimated $4K.
MBE Wealth Management first reported a position in Gilead Sciences in Q1 2020 and held it in 1 quarter.
MBE Wealth Management's Gilead Sciences position peaked at $4K in Q1 2020.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on MBE Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.